ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Embecta Corporation

Embecta Corporation (EMBC)

15.76
0.19
( 1.22% )
Updated: 09:05:15

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
15.76
Bid
15.76
Ask
15.81
Volume
18,930
15.57 Day's Range 15.81
9.925 52 Week Range 23.75
Market Cap
Previous Close
15.57
Open
15.58
Last Trade
52
@
15.81
Last Trade Time
09:05:15
Financial Volume
US$ 296,072
VWAP
15.6404
Average Volume (3m)
450,440
Shares Outstanding
57,670,209
Dividend Yield
3.81%
PE Ratio
12.75
Earnings Per Share (EPS)
1.22
Revenue
1.12B
Net Profit
70.4M

About Embecta Corporation

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Embecta Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker EMBC. The last closing price for Embecta was US$15.57. Over the last year, Embecta shares have traded in a share price range of US$ 9.925 to US$ 23.75.

Embecta currently has 57,670,209 shares outstanding. The market capitalization of Embecta is US$897.93 million. Embecta has a price to earnings ratio (PE ratio) of 12.75.

EMBC Latest News

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company PR Newswire NEW YORK, July 29, 2024 Genpact's deep domain knowledge and data expertise enables embecta's vision to...

embecta to Report Fiscal Third Quarter 2024 Financial Results

PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts...

Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and...

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and...

embecta to Participate in Investor Events

PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
11.218.3161512027514.5516.5314.4464320415.88461173CS
43.2325.77813248212.5316.5311.4642285213.87087481CS
125.5354.056695992210.2316.5310.1545044013.27450458CS
26-1.54-8.9017341040517.317.999.92543781313.36943169CS
52-5.48-25.800376647821.2423.759.92549738815.55291462CS
156-16.6-51.297898640332.3636.649.92565993024.4010747CS
260-16.6-51.297898640332.3636.649.92565993024.4010747CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LIPOLipella Pharmaceuticals Inc
US$ 1.16
(187.06%)
123.1M
YIBOPlanet Image International Ltd
US$ 5.37
(84.22%)
19.92M
TWOU2U Inc
US$ 2.0693
(65.54%)
6.22M
TIVCTivic Health Systems Inc
US$ 0.6438
(42.43%)
45.83M
VEROVenus Concept Inc
US$ 0.86
(34.38%)
385.19k
VTVTvTv Therapeutics Inc
US$ 13.00
(-38.68%)
51.57k
CGTXCognition Therapeutics Inc
US$ 1.48
(-37.55%)
15.43M
CEROCERo Therapeutics Holdings Inc
US$ 0.173
(-32.42%)
4.24M
VTYXVentyx Biosciences Inc
US$ 2.20
(-25.42%)
1.16M
IARTIntegra LifeSciences Holdings Corporation
US$ 24.0394
(-23.51%)
1.58M
LIPOLipella Pharmaceuticals Inc
US$ 1.16
(187.06%)
123.1M
NLSPNLS Pharmaceutics Ltd
US$ 0.2531
(33.21%)
84.96M
NVDANVIDIA Corporation
US$ 115.61
(2.26%)
48.51M
TIVCTivic Health Systems Inc
US$ 0.6438
(42.43%)
45.83M
SQQQProShares UltraPro Short QQQ
US$ 8.85
(-2.75%)
33.22M

Your Recent History

Delayed Upgrade Clock